Treeline Biosciences is a biotech company dedicated to developing transformative precision medicines for patients with cancer and other serious conditions. Their core mission is to leverage cutting-edge scientific research to create targeted therapies that address unmet medical needs, focusing on delivering innovative solutions to improve patient outcomes.
Treeline Biosciences has made significant strides in the field of precision medicine, contributing to advancements in cancer treatment and other critical health areas. Their impactful work has garnered attention within the biotech community, positioning them as a key player in the development of next-generation therapies.
Treeline Biosciences
- Company Overview
Operating Status
Active
Ownership Type(s)
Venture Capital, Equity
Main Product(s)
Precision Medicines
Technology
Biotech
Tags
Healthtech
Treeline Biosciences
- Operating Model
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Global
Treeline Biosciences - FAQ
When was Treeline Biosciences founded?
Treeline Biosciences was founded in 2021.
Where is Treeline Biosciences's headquarters located?
Treeline Biosciences's headquarters is located in Watertown, MA, US.
When was Treeline Biosciences's last funding round?
Treeline Biosciences's most recent funding round was for $261.3M (USD) in October 2022.
How many employees does Treeline Biosciences have?
Treeline Biosciences has 166 employees as of Feb 5, 2024.
How much has Treeline Biosciences raised to-date?
As of July 05, 2023, Treeline Biosciences has raised a total of $473.3M (USD) since Oct 11, 2022.
Treeline Biosciences - Comparables
Add Comparison
Treeline Biosciences - Fundraising
Total Raised to Date
$473.3M
USD
Last Update Oct 11, 2022
Last Deal Details
$261.3M
USD
Oct 11, 2022
Series A
Treeline Biosciences - Employees
Total Employees Over Time
166
As of Feb 2024
Treeline Biosciences - Contact Information
Treeline Biosciences Address
Watertown,
Massachusetts
02472
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.